Reviewed Mar 2026 | PubMed sources
Active Market
Netherlands is selected. The evidence comparison is still valid, but provider availability, legal positioning, and cost assumptions may still be staged for later rollout.

Bremelanotide vs Melanotan II: Head-to-Head Comparison

Bremelanotide (PT-141/Vyleesi) is FDA-approved for hypoactive sexual desire disorder in premenopausal women. Melanotan II is an unregulated research peptide that affects sexual function, tanning, and appetite through broad melanocortin receptor activation. Bremelanotide was derived from Melanotan II but is more selective.

Approved Comparison Routing

Approved options in this comparison

A
Bremelanotide (PT-141)

Bremelanotide (PT-141) is currently modeled on this site as an approved treatment path for: Hypoactive sexual desire disorder (HSDD) in premenopausal women. Brand names in the current dataset: Vyleesi.

Validation note: This block reflects the site's current structured treatment data and internal routing logic. It does not replace checking current labeling, payer rules, or local prescribing conditions.

Want to discuss Bremelanotide (PT-141) with a provider?

Bremelanotide (PT-141) is currently modeled on this site as an approved treatment path. Use the provider matcher to narrow fit by state, insurance, budget, and urgency.

Join provider rollout

Side-by-Side Comparison

DimensionBremelanotideMelanotan II
Evidence LevelPhase III trials, FDA-approvedLimited clinical data; mostly anecdotal
FDA StatusFDA-approved (Vyleesi) for HSDDNot approved; banned in several countries
MechanismMC4R agonist (selective melanocortin)Non-selective MC1R/MC3R/MC4R/MC5R agonist
Side EffectsNausea, flushing, headache; transient BP increaseNausea, facial flushing, uncontrolled tanning, mole darkening, potential melanoma concern
Primary UseFemale sexual desire (HSDD)Tanning and sexual function (both sexes)
Route of AdministrationSubcutaneous auto-injector (on-demand)Subcutaneous injection or nasal spray
Safety ProfileWell-characterized; FDA-reviewed safety dataPoorly characterized; melanoma risk concerns
Evidence Level
Bremelanotide
Phase III trials, FDA-approved
Melanotan II
Limited clinical data; mostly anecdotal
FDA Status
Bremelanotide
FDA-approved (Vyleesi) for HSDD
Melanotan II
Not approved; banned in several countries
Mechanism
Bremelanotide
MC4R agonist (selective melanocortin)
Melanotan II
Non-selective MC1R/MC3R/MC4R/MC5R agonist
Side Effects
Bremelanotide
Nausea, flushing, headache; transient BP increase
Melanotan II
Nausea, facial flushing, uncontrolled tanning, mole darkening, potential melanoma concern
Primary Use
Bremelanotide
Female sexual desire (HSDD)
Melanotan II
Tanning and sexual function (both sexes)
Route of Administration
Bremelanotide
Subcutaneous auto-injector (on-demand)
Melanotan II
Subcutaneous injection or nasal spray
Safety Profile
Bremelanotide
Well-characterized; FDA-reviewed safety data
Melanotan II
Poorly characterized; melanoma risk concerns

Peptide Overviews

Bremelanotide (PT-141)

AFDA Approved

Bremelanotide is a cyclic heptapeptide melanocortin receptor agonist approved by the FDA as Vyleesi for treatment of hypoactive sexual desire disorder (HSDD) in premenopausal women.

Sexual HealthFDA Approved
View full Bremelanotide (PT-141) profile →

Melanotan II

CPreclinical

Melanotan II (also written as Melanotan 2, MT-2, or MT2) is a synthetic cyclic peptide analog of alpha-melanocyte stimulating hormone (alpha-MSH). Originally developed for skin tanning — sometimes informally called the 'tanning peptide' or 'Barbie drug' — it also has sexual arousal effects but significant safety concerns.

Sexual HealthNot Approved
View full Melanotan II profile →

GLP-1 Support Essentials

Products that can support side-effect management, hydration, and protein intake.

Amazon affiliate links; we may earn a small commission at no extra cost to you. See our disclosure.

Supplies for Both

Common research handling and preparation supplies for injectable peptide workflows.

Amazon affiliate links; we may earn a small commission at no extra cost to you. See our disclosure.

Recommended Reading

Books covering peptide science, longevity research, and biohacking frameworks.

Amazon affiliate links; we may earn a small commission at no extra cost to you. See our disclosure.

Bremelanotide vs Melanotan II: FAQ